Publicacións nas que colabora con DAVID FRAGUAS HERRÁEZ (40)

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

2022

  1. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

    Molecular Autism, Vol. 13, Núm. 1

  2. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 2, pp. 74-87

2021

  1. Fronto-parietal gray matter volume loss is associated with decreased working memory performance in adolescents with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  2. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

    Translational Psychiatry, Vol. 11, Núm. 1

  3. The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 11

2020

  1. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): Systematic review and meta-regression analysis

    Molecular Autism, Vol. 11, Núm. 1

  2. The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in young people with autism and schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 3, pp. 118-130

2019

  1. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis

    Pediatrics, Vol. 144, Núm. 5

  2. Neuroanatomical deficits shared by youth with autism spectrum disorders and psychotic disorders

    Human Brain Mapping, Vol. 40, Núm. 5, pp. 1643-1653

2017

  1. Atypical age-dependency of executive function and white matter microstructure in children and adolescents with autism spectrum disorders

    European Child and Adolescent Psychiatry, Vol. 26, Núm. 11, pp. 1361-1376

  2. Gene-environment interaction as a predictor of early adjustment in first episode psychosis

    Schizophrenia Research, Vol. 189, pp. 196-203

2015

  1. Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis

    European Child and Adolescent Psychiatry, Vol. 24, Núm. 12, pp. 1447-1459

  2. Predictors of outcome in early-onset psychosis: A systematic review

    npj Schizophrenia, Vol. 1, Núm. 1

2014

  1. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 126-133

  2. Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders

    Schizophrenia Bulletin, Vol. 40, Núm. SUPPL. 2

  3. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study

    Schizophrenia Research, Vol. 152, Núm. 1, pp. 130-138

  4. Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 53, Núm. 11, pp. 1179-1190.e4

2013

  1. Structural magnetic resonance imaging data do not help support DSM-5 autism spectrum disorder category

    Research in Autism Spectrum Disorders, Vol. 7, Núm. 2, pp. 333-343